Seeking Alpha

GALT
  Galectin Therapeutics, Inc. - NASDAQ

8/20/2014, 7:06 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
GALT vs. ETF Alternatives
Company Description
Galectin Therapeutics, Inc. is a development-stage company engaged in drug research and development to create new therapies for fibrotic disease and cancer.
Sector: Healthcare
Industry: Drugs - Generic
Country: United States